$13.69
+0.38 (+2.86%)
Open$13.39
Previous Close$13.31
Day High$13.86
Day Low$13.38
52W High$20.03
52W Low$12.52
Volume—
Avg Volume118.8K
Market Cap171.71M
P/E Ratio—
EPS$-1.60
SectorPharmaceuticals
Analyst Ratings
Strong Buy
12 analysts
Price Target
+184.4% upside
Current
$13.69
$13.69
Target
$38.94
$38.94
$25.16
$38.94 avg
$46.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 19.22M | 22.30M | 84.88M |
| Net Income | -27,057,986 | -28,257,353 | 12.73M |
| Profit Margin | -140.8% | -133.8% | 15.0% |
| EBITDA | -27,360,922 | -30,161,146 | 16.15M |
| Free Cash Flow | — | — | 13.25M |
| Rev Growth | -13.8% | -13.8% | +19.4% |
| Debt/Equity | 0.20 | 0.20 | 1.84 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |